for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Eli Lilly And Co

LLY.N

Latest Trade

108.64USD

Change

0.18(+0.17%)

Volume

930,678

Today's Range

107.90

 - 

108.92

52 Week Range

104.19

 - 

132.12

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
108.46
Open
108.31
Volume
930,678
3M AVG Volume
71.59
Today's High
108.92
Today's Low
107.90
52 Week High
132.12
52 Week Low
104.19
Shares Out (MIL)
965.43
Market Cap (MIL)
104,884.60
Forward P/E
19.14
Dividend (Yield %)
2.37

Next Event

Q3 2019 Eli Lilly and Co Earnings Release

Latest Developments

More

PhRMA Names Eli Lilly Chairman And CEO, David Ricks, As Chairman-Elect

Lilly Announces Phase 3 Study In Patients With Metastatic Pancreatic Cancer Did Not Meet Primary Endpoint Of Overall Survival

Eli Lilly Announces Voluntary Delisting From Euronext Paris

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Eli Lilly And Co

Eli Lilly and Company is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products. The Company's human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists. Its animal health business segment develops, manufactures and markets products for both food animals and companion animals. The Company's human pharmaceutical products include endocrinology products, neuroscience products, oncology products, immunology products and cardiovascular products. The Company's animal health products segment includes products for food animals and products for companion animals. As of December 31, 2018, the Company manufactured and distributed its products through facilities in the United States, Puerto Rico and 14 other countries.

Industry

Biotechnology & Drugs

Contact Info

Lilly Corporate Ctr, Drop Code 1112

+1.317.2762000

https://www.lilly.com/

Executive Leadership

David A. Ricks

Chairman of the Board, President, Chief Executive Officer

Joshua L. Smiley

Chief Financial Officer, Senior Vice President

Michael J. Harrington

Executive Vice President, General Counsel

Aarti S. Shah

Senior Vice President - Chief Information and Digital Officer

Daniel M. Skovronsky

Senior Vice President, Chief Scientific Officer

Key Stats

2.40 mean rating - 15 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

21.2K

2017

22.9K

2018

24.6K

2019(E)

22.3K
EPS (USD)

2016

3.520

2017

4.280

2018

5.550

2019(E)

5.677
Price To Earnings (TTM)
24.70
Price To Sales (TTM)
4.52
Price To Book (MRQ)
37.74
Price To Cash Flow (TTM)
18.39
Total Debt To Equity (MRQ)
567.75
LT Debt To Equity (MRQ)
493.35
Return on Investment (TTM)
15.50
Return on Equity (TTM)
10.71

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up